Short-term androgen deprivation therapy for patients with intermediate-risk prostate cancer undergoing dose-escalated radiotherapy: the standard of care?-Reference-Cited by-同舟云学术

Short-term androgen deprivation therapy for patients with intermediate-risk prostate cancer undergoing dose-escalated radiotherapy: the standard of care?

Published:2012-06 Issue:6 Volume:13 Page:e259-e269
ISSN:1470-2045
Container-title:The Lancet Oncology
language:en
Short-container-title:The Lancet Oncology

Author:

Zumsteg Zachary S,Zelefsky Michael J

Publisher

Elsevier BV

Subject

Oncology

Reference82 articles.

1. Radiotherapy and short-term androgen deprivation for localized prostate cancer;Jones;N Engl J Med,2011

2. Androgen suppression and radiation vs radiation alone for prostate cancer: a randomized trial;D'Amico;JAMA,2008

3. National practice patterns and time trends in androgen ablation for localized prostate cancer;Cooperberg;J Natl Cancer Inst,2003

4. Androgen deprivation use with external beam radiation for prostate cancer: results from CaPSURE;Park;J Urol,2005

5. NCCN clinical practice guidelines in oncology: prostate cancer;Mohler;J Natl Compr Canc Netw,2010

Cited by 58 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Circulating tumour cells for early detection of clinically relevant cancer;Nature Reviews Clinical Oncology;2023-06-02

2. Genomic Prostate Score: A New Tool to Assess Prognosis and Optimize Radiation Therapy Volumes and ADT in Intermediate-Risk Prostate Cancer;Cancers;2023-02-02

3. Androgen deprivation therapy and radiotherapy in intermediate-risk prostate cancer: A systematic review and meta-analysis;Frontiers in Endocrinology;2023-01-17

4. Hypofractionated Radiotherapy in Intermediate-Risk Prostate Cancer Patients: Long-Term Results;Journal of Clinical Medicine;2022-08-16

5. Personalization of Treatment Intensity for Intermediate-Risk Prostate Cancer;International Journal of Radiation Oncology*Biology*Physics;2022-03